BROWSE BY TOPIC
- Bad Brokers
- Compliance Concepts
- Investor Protection
- Investments - Unsuitable
- Investments - Strategies
- Investments - Private
- Features/Scandals
- Companies
- Technology/Internet
- Rules & Regulations
- Crimes
- Investments
- Bad Advisors
- Boiler Rooms
- Hirings/Transitions
- Terminations/Cost Cutting
- Regulators
- Wall Street News
- General News
- Donald Trump & Co.
- Lawsuits/Arbitrations
- Regulatory Sanctions
- Big Banks
- People
TRENDING TAGS
Stories of Interest
- Sarah ten Siethoff is New Associate Director of SEC Investment Management Rulemaking Office
- Catherine Keating Appointed CEO of BNY Mellon Wealth Management
- Credit Suisse to Pay $47Mn to Resolve DOJ Asia Probe
- SEC Chair Clayton Goes 'Hat in Hand' Before Congress on 2019 Budget Request
- SEC's Opening Remarks to the Elder Justice Coordinating Council
- Massachusetts Jury Convicts CA Attorney of Securities Fraud
- Deutsche Bank Says 3 Senior Investment Bankers to Leave Firm
- World’s Biggest Hedge Fund Reportedly ‘Bearish On Financial Assets’
- SEC Fines Constant Contact, Popular Email Marketer, for Overstating Subscriber Numbers
- SocGen Agrees to Pay $1.3 Billion to End Libya, Libor Probes
- Cryptocurrency Exchange Bitfinex Briefly Halts Trading After Cyber Attack
- SEC Names Valerie Szczepanik Senior Advisor for Digital Assets and Innovation
- SEC Modernizes Delivery of Fund Reports, Seeks Public Feedback on Improving Fund Disclosure
- NYSE Says SEC Plan to Limit Exchange Rebates Would Hurt Investors
- Deutsche Bank faces another challenge with Fed stress test
- Former JPMorgan Broker Files racial discrimination suit against company
- $3.3Mn Winning Bid for Lunch with Warren Buffett
- Julie Erhardt is SEC's New Acting Chief Risk Officer
- Chyhe Becker is SEC's New Acting Chief Economist, Acting Director of Economic and Risk Analysis Division
- Getting a Handle on Virtual Currencies - FINRA
ABOUT FINANCIALISH
We seek to provide information, insights and direction that may enable the Financial Community to effectively and efficiently operate in a regulatory risk-free environment by curating content from all over the web.
Stay Informed with the latest fanancialish news.
SUBSCRIBE FOR
NEWSLETTERS & ALERTS
Law Firm, Analyst, Lobbyist Subpoenaed Over Leak
Washington, D.C. Players Being Probed.
[ by Melanie Gretchen ]
Joined by the FBI and the U.S. Department of Labor, the SEC has issued subpoenas as part of a wider probe into a possible leak of a 4/1/13 decision on government payment rates for private Medicare health insurance plans for seniors, known as "Medicare Advantage."
The SEC subpoenaed:
- Height Securities' health care analyst.
- Greenberg Traurig's Washington, D.C. office.
- Mark Hayes, a healthcare lobbyist who supposedly advised the capital markets firm and his law firm about the Medicare changes.
The probe began after The WSJournal first reported the issue last month and said a report by Height - which said the announcement would favor insurers - may have prompted the stock swing.
Continue reading this post for the full text of the Reuters story, or click the link below to access the referenced article.
****************************************************************
Regulators subpoena law firm, lobbyist in healthcare case - report
5/2/2013 COMMENTS (0)
WASHINGTON (Reuters) - U.S. regulators are investigating a Washington-based law firm, a securities analyst and healthcare lobbyist and have issued subpoenas as part of a wider probe, according to a media report.
The Securities and Exchange Commission has subpoenaed an analyst with Height Securities and Mark Hayes, a lobbyist who advised the capital markets firm, as well as Hayes' law firm Greenberg Traurig, The Washington Post reported, citing sources who could not be named because of the investigation.
The Federal Bureau of Investigation and the U.S. Department of Justice are also involved in the probe, according to the report published on the newspaper's website late Wednesday.
SEC spokesman John Nestor declined to comment to Reuters on the report. Justice Department spokeswoman Nanda Chitre said the department could not confirm or deny whether the incident was under investigation.
Attorneys and company officials for the parties involved have denied any wrongdoing, the Post said.
At issue is the possible leak of an April 1 decision on government payment rates for private Medicare health insurance plans for seniors known as Medicare Advantage. The government said it would raise reimbursement rates, reversing an initial proposal from February to cut the rate 2.3 percent.
The probe began after a report last month in The Wall Street Journal, which first reported the issue and said a report by Height - saying the announcement would favor insurers - may have prompted the stock swing, the Washington Post said.
Companies whose share prices surged on the possible leak included Humana Inc, which derives about two-thirds of its revenue from the Medicare Advantage Business, UnitedHealth Group Inc and Aetna Inc.
The potential leak highlights the so-called "political intelligence" industry where Washington power players with close ties try to advise Wall Street on legislative affairs, regulations and other government actions that can affect various industries.
Centers for Medicare and Medicaid Services' Acting Administrator Marilyn Tavenner last month told a Senate panel that the potential leak was "a huge issue," and vowed to do an internal review.
Humana has also announced an internal review of the events around the April 1 announcement.
Investigators with the Government Accountability Office, the investigative arm of Congress, said last month that the agency could not put a price tag on the sales of political intelligence or how much of that insider information was actually flowing.EEFV
"What is most difficult to measure is the extent to which investment decisions are based on a single piece of government information or political intelligence," they wrote in a report requested by Congress before the current incident.

